Search for: "Nature's Way Products, Inc. v. Nature-Pharma, Inc."
Results 21 - 40
of 52
Sorted by Relevance
|
Sort by Date
19 Sep 2013, 9:53 am
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
9 Apr 2015, 5:00 am
Two other state supreme courts have reaffirmed the learned intermediary rule since then, Wyeth, Inc. v. [read post]
9 Dec 2015, 6:50 am
The rumblings began shortly after the industry First Amendment victory over the FDA in Amarin Pharma, Inc. v. [read post]
17 Sep 2009, 4:30 am
Medtronic, Inc., 128 S. [read post]
1 Mar 2014, 6:22 am
., : COMPLAINT AND DEMAND: FOR JURY TRIALPlaintiff, ::v. :: Case No. 1:14-cv-879AbbVie Inc., and :Abbott Laboratories, Inc., ::Defendants. [read post]
4 Jan 2012, 3:04 pm
* Yahoo Inc. v. [read post]
18 Feb 2010, 10:34 am
Because those are federal statutes, they can’t be “preempted” the way state-law claims were in Buckman Co. v. [read post]
25 Jul 2008, 2:11 am
See Aventis Pharma Deutschland GmbH v. [read post]
11 Oct 2017, 8:17 am
Jadebay: something you may not know about Amazon listings, but probably shouldJadebay v Clarke-Coles (t/a Feel Good UK) [2017] EWHC 1400 (IPEC) (June 2017)Feel Good listed their flagpole products in a way which made them look like Jadebay’s “Design Elements” flagpoles. [read post]
28 Jun 2007, 10:16 am
Purdue Pharma Co., 297 F. [read post]
2 Apr 2013, 10:33 am
Ltd. v. [read post]
25 Jun 2009, 4:29 am
In re Amgen Inc. [read post]
8 Nov 2024, 9:28 am
Simultaneously, we are witnessing a technological revolution that is reshaping the very nature of work. [read post]
7 Feb 2008, 10:46 am
§10.85.The non-preemption way of challenging FDCA-violation/negligence per se claims relies upon what are entirely state-law grounds, but which operate in the context of Congress and the FDCA. [read post]
19 Jul 2022, 2:59 pm
Effective legal counsel can help companies manage their disclosures in a way that allows for optimistic statements while protecting against future litigation. [read post]
16 Sep 2010, 1:22 pm
GSK is pharma company with a large local presence (for more about that, see this post). [read post]
12 Aug 2016, 4:49 pm
[People v. firms? [read post]
23 Sep 2011, 12:08 pm
Purdue Pharma L.P., 292 F.Supp.2d 1346, 1354 (S.D. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over Special 301… [read post]
27 Oct 2014, 5:27 am
KG v Stokke A/S, Stokke Nederland BV, Peter Opsvik and Peter Opsvik A/S, a decision where the CJEU addressed the trade mark absolute grounds of “substantial value” and “shape which results from the nature of the goods themselves”. [read post]
